$90.61
$-2.37 (-2.55%)
End-of-day quote: 05/17/2024
NasdaqGS:BNTX
BioNTech Competitors
| Ticker | Name | Exchange | Consensus | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | NYSE | Outperform | $154.64 | $174.55 | 0.00% | 3 | $372.17B |
| MRK | Merck | NYSE | Outperform | $131.19 | $130.51 | 0.00% | 11 | $332.28B |
| AZN | AstraZeneca PLC | LSE | Outperform | £121.10 | £165.99 | 0.00% | 16 | £187.73B |
| PFE | Pfizer | NYSE | Outperform | $28.64 | $32.87 | 0.00% | 6 | $162.29B |
| SAN | Sanofi | ENXTPA | Outperform | 89.17€ | 102.80€ | 0.00% | 9 | 111.47€B |
| GSK | GSK | LSE | Outperform | £17.75 | £17.30 | 0.00% | 12 | £72.39B |
| MRNA | Moderna | NasdaqGS | Outperform | $132.90 | $135.42 | 0.00% | 1 | $50.93B |
| LONN | Lonza Group | SWX | Buy | CHF529.20 | CHF516.89 | 0.00% | 8 | CHF38.16B |
| 4502 | Takeda Pharmaceutical Company | TSE | Outperform | ¥4.13k | ¥4.74k | 0.00% | 0 | ¥6.48T |
| NVAX | Novavax | NasdaqGS | Outperform | $13.01 | $23.25 | 0.00% | 4 | $623.13M |
| CVAC | CureVac N.V. | NasdaqGM | Outperform | $3.49 | $12.92 | 0.00% | 1 | $564.45M |
| VLA | Valneva | ENXTPA | Outperform | 4.10€ | 9.32€ | 0.00% | 0 | 474.10€M |
| VBIV | VBI Vaccines | NasdaqCM | Outperform | $0.63 | $6.00 | 0.00% | 0 | $18.27M |
